Viewing Study NCT06795893


Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2025-12-30 @ 10:27 AM
Study NCT ID: NCT06795893
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-01-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Anifrolumab PRIM Program
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module